Proposal of initial and maintenance dosing regimens with linezolid for renal impairment patients

Overview of attention for article published in BMC Pharmacology and Toxicology, March 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#45 of 487)
High Attention Score compared to outputs of the same age (84th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 6,805 followers.

RT @kadsho: #リネゾリド腎不全患者で初回600mg q12h 2日間⇒300mg q12h 維持に減量でCmin>2で血小板減少が少なかった。富山大学感染症学講座からの報告 Proposal of initial and maintenance dosing r…

Came in to a patient on Linezolid 300mg Q12H and found this article? What are your thoughts? @IDstewardship @accpinfdprn @IDSAInfo https://t.co/vIOss38Dwx

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.